- Home
- DEA vs BVS Comparison
DEA vs BVS Comparison
Compare DEA & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DEA | BVS |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 910.2M |
| IPO Year | 2014 | 2016 |
Fundamental Metrics
Financial Performance| Metric | DEA | BVS |
|---|---|---|
| Price | $22.53 | $10.67 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $25.21 | $17.60 |
| AVG Volume (30 Days) | 406.0K | ★ 555.8K |
| Earning Date | 10-26-2026 | 11-02-2026 |
| Dividend Yield | ★ 7.99% | N/A |
| EPS Growth | 50.00 | ★ 163.46 |
| EPS | 0.20 | ★ 0.60 |
| Revenue | $336,099,000.00 | ★ $568,087,000.00 |
| Revenue This Year | $8.22 | $5.42 |
| Revenue Next Year | $2.29 | $6.72 |
| P/E Ratio | $116.40 | ★ $19.03 |
| Revenue Growth | ★ 11.27 | N/A |
| 52 Week Low | $20.56 | $6.47 |
| 52 Week High | $25.96 | $15.89 |
Technical Indicators
Market Signals| Indicator | DEA | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 45.62 | 30.04 |
| Support Level | $21.35 | $8.21 |
| Resistance Level | $23.83 | $11.00 |
| Average True Range (ATR) | 0.52 | 0.72 |
| MACD | 0.06 | -0.45 |
| Stochastic Oscillator | 41.85 | 9.73 |
Price Performance
Historical ComparisonAbout DEA Easterly Government Properties Inc.
Easterly Government Properties Inc is a real estate investment trust. The company is engaged in the acquisition, development, and management of Class A commercial properties that are leased to U.S. government agencies. It generates all its revenue by leasing its properties to such agencies. The company operates in single segment for the purposes of assessing performance and making operating decisions.
About BVS Bioventus Inc.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.